Ligand validation:4EYQ

ENO: 3-(4-HYDROXY-PHENYL)PYRUVIC ACID

ENO is a Ligand Of Interest in 4EYQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EYQ_ENO_A_401	84%	62%	0.106	0.967	0.56	0.88	-	-	1	0	100%	0.5
3TX6_ENO_A_386	95%	44%	0.071	0.973	1.37	0.84	1	-	0	0	100%	1
4JB0_ENO_A_402	92%	35%	0.086	0.977	1.55	1.12	1	1	1	0	100%	0.2
3UKJ_ENO_A_401	85%	42%	0.084	0.95	0.9	1.37	-	2	0	0	100%	1
3UK0_ENO_A_501	90%	14%	0.069	0.953	2.43	1.62	2	3	1	0	100%	1
4KIG_ENO_A_501	87%	54%	0.101	0.974	0.69	1.07	-	1	0	0	100%	1
3GGO_ENO_B_3168	83%	25%	0.102	0.96	1.92	1.27	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.